CCP
BIIB icon

Clough Capital Partners’s Biogen BIIB Stock Holding History

Clough Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-42,800
Closed -$9.92M – 135
2024
Q2 		$9.92M Buy
+42,800
New +$9.3M 1.08% 37
2019
Q1 		– Sell
-11,485
Closed -$3.46M – 132
2018
Q4 		$3.46M Buy
11,485
+2,288
+25% +$730K 0.41% 70
2018
Q3 		$3.25M Sell
9,197
-875
-9% -$301K 0.31% 70
2018
Q2 		$2.92M Sell
10,072
-2,485
-20% -$699K 0.26% 74
2018
Q1 		$3.44M Sell
12,557
-15,160
-55% -$4.71M 0.33% 71
2017
Q4 		$8.83M Sell
27,717
-24,955
-47% -$8.01M 0.74% 50
2017
Q3 		$16.5M Sell
52,672
-550
-1% -$163K 1.11% 30
2017
Q2 		$14.4M Sell
53,222
-3,122
-6% -$826K 1% 29
2017
Q1 		$15.4M Sell
56,344
-6,635
-11% -$1.88M 0.98% 30
2016
Q4 		$17.9M Buy
62,979
+19,049
+43% +$5.65M 1.18% 28
2016
Q3 		$13.8M Buy
+43,930
New +$13M 0.72% 50
2015
Q3 		– Sell
-78,386
Closed -$31.7M – 200
2015
Q2 		$31.7M Buy
+78,386
New +$31.5M 1.21% 23
2014
Q4 		– Sell
-82,130
Closed -$27.2M – 179
2014
Q3 		$27.2M Sell
82,130
-1,200
-1% -$396K 1.02% 35
2014
Q2 		$26.3M Buy
83,330
+34,416
+70% +$10.4M 0.83% 40
2014
Q1 		$15M Sell
48,914
-23,742
-33% -$7.54M 0.47% 84
2013
Q4 		$20.3M Sell
72,656
-24,100
-25% -$6.23M 0.67% 55
2013
Q3 		$23.3M Buy
96,756
+59,300
+158% +$13.3M 0.72% 49
2013
Q2 		$8.06M Buy
+37,456
New +$8M 0.27% 121

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Clough Capital Partners's BIIB Position: Q3 2024 in Review

Clough Capital Partners sold out of Biogen (BIIB) in Q3 2024, closing a stake of 42,800 shares — an estimated $9.92M sold.

Clough Capital Partners first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $31.7M in Q2 2015. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Clough Capital Partners reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Clough Capital Partners sold 42,800 Biogen shares in Q3 2024, an estimated $9.92M.
  • Clough Capital Partners first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
  • Clough Capital Partners's Biogen position peaked at $31.7M in Q2 2015.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Clough Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.